References
-
1) Novel long non‐coding RNA CYB561‐5 promotes aerobic glycolysis and tumorigenesis by interacting with basigin in non‐small cell lung cancer.
-
2) Therapeutic effects of quinine in a mouse model of atopic dermatitis.
Product: Filaggrin Antibody (#DF13653)Year: 2021Journal: MOL MED REPImpactFactor: 3.4DOI: 10.3892/mmr.2021.11952PMID: 34240224 -
3) Glutamine‐based Metabolism Normalization and Oxidative Stress Alleviation by Self‐assembled bilirubin/V9302 Nanoparticles for Psoriasis Treatment.
Product: SLC1A5 Antibody (#DF13643)Year: 2023Journal: ADV HEALTHC MATERImpactFactor: 10DOI: 10.1002/adhm.202203397PMID: 36690435 -
4) Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
Product: ILF1 Antibody (#DF13638)Year: 2023Journal: ONCOTARGETS THERImpactFactor: 4DOI: 10.2147/OTT.S255956PMID: 32982306 -
5) Anti-Tim4 Grafting Strongly Hydrophilic Metal–Organic Frameworks Immunoaffinity Flake for High-Efficiency Capture and Separation of Exosomes.
Product: TIM 4 Antibody (#DF13636)Year: 2021Journal: Anal. Chem.ImpactFactor: 7.4DOI: 10.1021/acs.analchem.1c00528PMID: 33851819 -
6) Identification by RNA-Seq of let-7 clusters as prenatal biomarkers for nonsyndromic cleft lip with palate.
Product: Hhip Antibody (#DF13634)Year: 2022Journal: Ann N Y Acad SciImpactFactor: 5.2DOI: 10.1111/nyas.14868PMID: 35854669 -
7) Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer.
-
8) PTBP1 knockdown promotes neural differentiation of glioblastoma cells through UNC5B receptor.
-
9) miR-106b-5p upregulation is associated with microglial activation and inflammation in the mouse hippocampus following status epilepticus.
-
10) Analysis of the risk of traumatic brain injury and evaluation neurogranin and myelin basic protein as potential biomarkers of traumatic brain injury in postmortem examination.
Product: Neurogranin Antibody (#DF13620)Year: 2022Journal: Forensic Sci Med PatholImpactFactor: 1.8DOI: 10.1007/s12024-022-00459-4PMID: 35201602 -
11) Netrin-1 protects blood-brain barrier (BBB) integrity after cerebral ischemia-reperfusion by activating the Kruppel-like factor 2 (KLF2)/occludin pathway.
Product: KLF2 Antibody (#DF13602)Year: 2024Journal: J Biochem Mol ToxicolImpactFactor: 3.6DOI: 10.1002/jbt.23623PMID: 38229322 -
12) FGF2 Alleviates Microvascular Ischemia-Reperfusion Injury by KLF2-mediated Ferroptosis Inhibition and Antioxidant Responses.
Product: KLF2 Antibody (#DF13602)Year: 2023Journal: Int J Biol SciImpactFactor: 9.2DOI: 10.7150/ijbs.85692PMID: 37705747 -
13) Bioinformatics analysis of KLF2 as a potential prognostic factor in ccRCC and association with epithelial‑mesenchymal transition.
Product: KLF2 Antibody (#DF13602)Year: 2022Journal: EXP THER MEDImpactFactor: 2.7DOI: 10.3892/etm.2022.11498PMID: 35978925 -
14) PC (16:0/14:0) ameliorates hyperoxia-induced bronchopulmonary dysplasia by upregulating claudin-1 and promoting alveolar type II cell repair.
Year: 2024Journal: Int J Biochem Cell BiolImpactFactor: 4DOI: 10.1016/j.biocel.2024.106587PMID: 38740281 -
15) GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17.
Year: 2024Journal: Int ImmunopharmacolImpactFactor: 5.6DOI: 10.1016/j.intimp.2024.111603PMID: 38310766